Hubei Biocause Heilen Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is MILRINONE, with a corresponding US DMF Number 19726.
Remarkably, this DMF maintains an Active status since its submission on August 31, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 30, 2013, and payment made on May 17, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II